This week, instead of pricings, look out for IPO launches. Recent updates from CAR T biotech Poseida Therapeutics (PSTX) and hospital chain Ardent Health (ARDT) make those deals more likely to launch. NASH biotech Genfit (GNFT) is able to start its roadshow later in the week, and close comp Cirius Therapeutics (CSTX) may decide to join the IPO calendar as well.
Five 2018 IPO lock-ups are expiring in the week ahead, including biotech Principia Biopharma (PRNB). Street research is expected for medical device maker Avedro (AVDR; BofA/JPM; -16% from IPO) and biotechs TCR2 Therapeutics (TCRR; Jefferies/Leerink; 4% from IPO) and Stealth Biotherapeutics (MITO; Jefferies/Evercore; +40% form IPO).
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.